Migraine and structural changes in the Brain: A systematic review and meta-analysis

Neurology

Volumn 81, Issue 14, 2013, Pages 1260-1268

  Bashir, Asma ^a   Lipton, Richard B ^b   Ashina, Sait ^b   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; BRAIN INFARCTION; CLINICAL PRACTICE; DISEASE ASSOCIATION; GRAY MATTER; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; WHITE MATTER;

BRAIN; BRAIN INFARCTION; HUMANS; LEUKOENCEPHALOPATHIES; MAGNETIC RESONANCE IMAGING; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA;

EID: 84888299015     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a6cb32     Document Type: Review

References (52)

1. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24 (suppl 1):1-151.
2. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population: A prevalence study. J Clin Epidemiol 1991;44:1147-1157.
3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41:646-657. (Pubitemid 32777747)
4. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Secular changes in health care utilization and work absence for migraine and tension-type headache: A population based study. Eur J Epidemiol 2005;20:1007-1014. (Pubitemid 41752619)
5. IMS Audit, January 1999. Available at: http://www. americanheadachesociety.org/assets/1/7/NAP-for-Web-Epidemiology-Impact-of- Headache-Migraine.pdf. Accessed January 5, 2013.
6. Moschiano F, D'Amico D, DiStefano M, Rocca N, Bussone G. The role of the clinician in interpreting conventional neuroimaging findings in migraine patients. Neurol Sci 2007;28:S114-S117. (Pubitemid 46813638)
7. Fazekas F, Koch M, Schmidt R, et al. The prevalence of cerebral damage varies with migraine type: An MRI study. Headache 1992;32:287-291.
8. Rovaris M, Bozzali M, Rocca MA, Colombo B, Filippi M. An MR study of tissue damage in the cervical cord of patients with migraine. J Neurol Sci 2001;183:43-46. (Pubitemid 32141071)
9. Rocca MA, Colombo B, Inglese M, Codella M, Comi G, Filippi M. A diffusion tensor magnetic resonance imaging study of brain tissue from patients with migraine. J Neurol Neurosurg Psychiatry 2003;74:501-503. (Pubitemid 36379376)
10. Kruit MC, van Buchem MA, Hofman PA, et al. Migraine as a risk factor for subclinical brain lesions. JAMA 2004; 291:427-434. (Pubitemid 38129746)
11. Kruit MC, Launer LJ, Ferrari MD, van Buchem MA. Brain Stem and cerebellar hyperintense lesions in migraine. Stroke 2006;37:1109-1112.
12. Degirmenci B, Yaman M, Haktanir A, Albayrak R, Acar M. Cerebral and cerebellar ADC values during a migraine attack. Neuroradiology 2007;49:419-426. (Pubitemid 46951327)
13. Kurth T, Mohamed S, Maillard P, et al. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ 2011;342:c7357.
14. Palm-Meinders IH, Koppen H, Terwindt GM, et al. Structural brain changes in migraine. JAMA 2012;308:1889-1897.
15. Kruit MC, Launer LJ, Ferrari MD, vanBuchem MA. Infarcts in the posterior circulation territory in migraine: The populationbased MRI CAMERA study. Brain 2005;128:2068-2077. (Pubitemid 41253274)
16. Scher AI, Gudmundsson LS, Sigurdsson S, et al. Migraine headache in middle age and late-life brain infarcts. JAMA 2009;301:2563-2570.
17. Rocca MA, Ceccarelli A, Falini A, et al. Brain gray matter changes in migraine patients with T2-visible lesions: A 3-T MRI study. Stroke 2006;37:1765-1770. (Pubitemid 44297727)
18. Dasilva AFM, Granziera C, Tuch DS, Snyder J, Vincent M, Hadjikhani N. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport 2007;18:301-305. (Pubitemid 46667957)
19. Schmidt-Wilcke T, Gänbbauer S, Neuner T, Bogdahn U, May A. Subtle grey matter changes between migraine patients and healthy controls. Cephalalgia 2008;28:1-4. (Pubitemid 350212641)
20. Valfre W, Rainero I, Bergui M, Pinessi L. Voxel-based morphometry reveals gray matter abnormalities in migraine. Headache 2008;48:109-117.
21. Kim JH, Suh SI, Seol HY, et al. Regional grey matter changes in patients with migraine: A voxel-based morphometry study. Cephalalgia 2008;28:598-604. (Pubitemid 351614929)
22. Schmitz N, Admiraal-Behloul F, Arkink EB, et al. Attack frequency and disease duration as indicators for brain damage in migraine. Headache 2008;48:1044-1055. (Pubitemid 351952082)
23. Schmitz N, Arkink EB, Mulder M, et al. Frontal lobe structure and executive function in migraine patients. Neurosci Lett 2008;440:92-96.
24. Jin C, Yuan K, Zhao L, et al. Structural and functional abnormalities in migraine patients without aura. NMR Biomed 2013;26:58-64.
25. Lipton RB, Pan J. Is migraine a progressive brain disease? JAMA 2004;291:493-494. (Pubitemid 38129755)
26. Lipton RB. Tracing transformation: chronic migraine classification, progression, and epidemiology. Neurology 2009;72(suppl 1):S3-S7.
27. Launer LJ, Terwindt GM, Ferrari MD. The prevalence and characteristics of migraine in a population-based cohort: The GEM study. Neurology 1999;53:537-542. (Pubitemid 29382048)
28. Matharu MS, Good CD, May A, Bahra A, Goadsby PJ. No change in the structure of the brain in migraine: A voxelbased morphometric study. Eur J Neurol 2003;10:53-57. (Pubitemid 36114942)
29. Fazekas F, Kleinert R, Offenbacher H, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-1689. (Pubitemid 23307935)
30. Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology 2008;71: 804-811.
31. Dinia L, Bonzano L, Albano B, et al. White matter lesions progression in migraine with aura: A clinical and MRI longitudinal study. J Neuroimaging 2013;23:47-52.
32. Jefferson AL, Tate DF, Poppas A, et al. Lower cardiac output is associated with greater white matter hyperintensities in older adults with cardiovascular disease. J Am Geriatr Soc 2007;55:1044-1048. (Pubitemid 47024621)
33. Shrestha I, Takahashi T, Nomura E, et al. Association between central systolic blood pressure, white matter lesions in cerebral MRI and carotid atherosclerosis. Hypertens Res 2009;32:869-874.
34. Trauninger A, Leél-Össy E, Kamson DO, et al. Risk factors of migraine-related brain white matter hyperintensities: An investigation of 186 patients. J Headache Pain 2011;12:97-103.
35. Ueno Y, Shimada Y, Tanaka R, et al. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients. Cerebrovasc Dis 2010;30:15-22.
36. Spence JD, Wong DG, Melendez LJ, Nichol PM, Brown JD. Increased prevalence of mitral valve prolapsed in patients with migraine. Can Med Assoc J 1984;131: 1457-1460. (Pubitemid 15193787)
37. Vahedi K, Chabriat H, Levy C, Joutel A, Tournier- Lasserve E, Bousser MG. Migraine with aura and brain magnetic resonance imaging abnormalities in patients with CADASIL. Arch Neurol 2004;61:1237-1240. (Pubitemid 39062677)
38. Hirano M, Ricci E, Koenigsberger MR, et al. MELAS: An original case and clinical criteria for diagnosis. Neuromuscul Disord 1992;2:125-135.
39. Filippi M, Rocca MA, De Stefano N, et al. Magnetic resonance techniques in multiple sclerosis. Arch Neurol 2011;68:1514-1520.
40. Rossato G, Adami A, Thijs VN, et al. Cerebral distribution of white matter lesions in migraine with aura patients. Cephalalgia 2010;30:855-859.
41. Rist PM, Dufouil C, Glymour MM, Tzourio C, Kurth T. Migraine and cognitive decline in the population-based EVA study. Cephalalgia 2011;31:1291-1300.
42. Buyck JF, Dufouil C, Mazoyer B, et al. Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: The 3-City Dijon study. Stroke 2009;40:2327-2331.
43. Hall GC, Brown MM, Mo J, MacRae KD. Triptans in migraine: The risks of stroke, cardiovascular disease, and death in practice. Neurology 2004;62:563-568. (Pubitemid 38252796)
44. Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MMB. Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan study. Stroke 2002;33:21-25. (Pubitemid 34052178)
45. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: A systematic review. Lancet Neurol 2007;6:611-619. (Pubitemid 46921055)
46. Kurth T, Tzourio C. Migraine and cerebral infarct-like lesions on MRI: An observation, not a disease. JAMA 2009;301:2594-2595.
47. Sándor PS, Mascia A, Seidel L, de Pasqua V, Schoenen J. Subclinical cerebellar impairment in the common types of migraine: A three-dimensional analysis of reaching movements. Ann Neurol. 2001;49:668-672. (Pubitemid 32429795)
48. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215-1222. (Pubitemid 36359297)
49. Schmidt-Wilcke T, Leinisch E, Straube A, et al. Gray matter decrease in patients with chronic tension type headache. Neurology 2005;65:1483-1486. (Pubitemid 41552788)
50. Welch KMA, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache 2001;41:629-637. (Pubitemid 32777745)
51. Kruit MC, Launer LJ, Overbosch J, van Buchem MA, Ferrari MD. Iron accumulation in deep brain nuclei in migraine: A population-based magnetic resonance imaging study. Cephalalgia 2008;29:351-359.
52. Guidelines from the American Academy of Neurology and US Headache Consortium: neuroimaging in patients with nonacute headache. Available at: http://tools.aan.com/professionals/practice/pdfs/gl0088.pdf. Accessed November 28, 2011.